Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Arie Belldegrun

Affiliations

  • at Allogene Therapeutics Inc. (ALLO), 2020-03-20
  • Director at Urogen Pharma Ltd. (URGN), 2020-02-13
  • Chairman, President And Ceo at Kite Pharma Inc. (KITE), 2017-10-06
  • Director at Arno Therapeutics Inc (ARNI), 2016-08-17
  • Director at Nile Therapeutics Inc. (NLTX), 2011-05-12
  • Director at Cougar Biotechnology Inc. (CGRB), 2009-07-07
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALLO $18.00 194,445 Director 1,691,781 2018-10-15 Filing
ALLO $18.00 35,000 Large Shareholder, Director 35,000 2018-10-15 Filing
KITE $68.57 17,000 Officer, Director 85,507 2017-05-09 Filing
ARNI $0.00 714,285 Director 2,262,838 2016-08-15 Filing
ARNI $0.35 714,285 Director 858,094 2016-01-12 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KITE $179.66 26,347 Officer, Director 109,160 2017-09-25 Filing
KITE $50.86 3,493 Officer, Director 24,707 2016-12-20 Filing